Capstone Turbine Corp. (CPST) Drops 9.93% on January 07

Equities Staff |

Capstone Turbine Corp. (CPST) was one of the Russell 2000's biggest losers for Thursday January 07 as the stock slid 9.93% to $1.32, a loss of $-0.145 per share. Starting at an opening price of $1.48 a share, the stock traded between $1.31 and $1.49 over the course of the trading day. Volume was 385,716 shares over 792 trades, against an average daily volume of 240,079 shares and a total float of 16.54 million.

The losses send Capstone Turbine Corp. down to a market cap of $21.74 million. In the last year, Capstone Turbine Corp. has traded between $15.36 and $1.16, and its 50-day SMA is currently $2.13 and 200-day SMA is $7.19.

Capstone Turbine Corp develops, manufactures, markets and services microturbine technology solutions used in stationary distributed power generation applications, including cogeneration, renewable energy, natural resources and critical power supply.

Capstone Turbine Corp. is based out of Chatsworth, CA and has some 236 employees. Its CEO is Darren R. Jamison.

For a complete fundamental analysis analysis of Capstone Turbine Corp., check out Equities.com’s Stock Valuation Analysis report for CPST. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…